About 1 in 15 solid organ transplant patients per year develop actinic keratosis (AK), with men, White individuals, and lung transplant recipients at highest risk. Data analysis was performed on 5484 ...
Woburn, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), and ...
The BLU-U Model 4170E offers a compact, easy-to-use option with the same BLU-U safety and efficacy healthcare professionals have trusted for years. The new LED BLU-U is approved for the same ...
5-Fluorouracil 4% cream achieved total clearance in 54.5% and partial clearance in 24.2% of hyperkeratotic actinic keratosis (AK) lesions at 3 months, demonstrating a good safety profile with high ...
Actinic keratosis (AK) is a common precancerous lesion arising from cumulative ultraviolet exposure, often heralding the development of non-melanoma skin cancers such as basal cell carcinoma and ...
Please provide your email address to receive an email when new articles are posted on . Current therapies do not prevent the onset of new lesions within a field of cancerization. Immune checkpoint ...
Hosted on MSN
Sun Pharma rises after USFDA approves next-gen Blue Light PDT device for actinic keratosis
"We are pleased to receive the FDA's approval of LED BLU-U and look forward to seeing the positive impact this next generation device will have for those living with actinic keratosis," said Abhay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback